Muhammad Sarfraz

Dr. Muhammad Sarfraz is an Associate Professor at the School of Pharmacy, University of Lahore, and Technical Lead at the Ocular Therapeutics Research Group (OTRG) of PMBRC-SETU. He holds a PhD in Pharmaceutics from Huazhong University of Science and Technology and completed postdoctoral research at Henan University. His research focuses on nano-drug delivery systems including liposomes, nanoparticles, nanogels, and nanoemulsions to address poor solubility and bioavailability issues in pharmaceuticals.

Education includes:

• PhD in Pharmaceutics, Huazhong University of Science and Technology (2017)
• Masters in Pharmaceutical Technology, Islamia University (2009)
• Bachelors in Pharmacy, Islamia University (2004)

Research interests center on developing innovative nanomedicine approaches for cancer treatment and ocular therapeutics, with particular expertise in tailoring nano-liposomal co-delivery systems and optimizing pharmaceutical formulations from lab to pilot scale. His work contributes to UN Sustainable Development Goals through improved healthcare solutions.

Publications demonstrate consistent focus on nanotechnology applications in drug delivery, with recent work advancing ocular drug formulations, analytical validation methods, and targeted cancer therapies. Research consistently bridges pharmaceutical science with clinical applications.